Loading stock data…
CVS Health Corporation (CVS)
$103.58-0.76 (-0.73%)
After Hours$103.58+0.00 (+0.00%)· Last close Jun 29
CVS Health Corporation provides health solutions in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
CVS Health Corporation in the Healthcare sector is trading at $103.58 with a market capitalization of $116.6B. Wall Street consensus targets $105.38 (26 analysts), implying a +1.7% move over the next 12 months. The stock is currently near its 52-week high of $106.15, remaining 29.1% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $100.43B↓ | $105.69B↑ | $102.87B↑ | $98.92B↑ | $94.59B |
| Gross Profit | $15.62B↑ | $13.57B↓ | $13.81B↑ | $13.59B↓ | $14.40B |
| Operating Income | $4.68B↑ | $2.11B↓ | $2.52B↑ | $2.38B↓ | $3.37B |
| Net Income | $2.94B | $2.94B↑ | -$3.98B↓ | $1.02B↓ | $1.78B |
Peer Comparison
JNJUNHPFE
Fundamentals
CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$116.58B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
40.07
Beta
Defensive asset. Lower volatility than the S&P 500.
0.59
Div Yield
Strong income play. Yield provides a meaningful total return floor.
2.59%
ROE
Average efficiency. Growth may require heavy reinvestment.
3.79%
Volume
Today's trading volume
3.30M
Recent News
CVS Health Corporation (CVS) Hits Fresh High: Is There Still Room to Run?
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
2 Healthcare Stocks with Competitive Advantages and 1 Facing Challenges
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 12.4% gain over the past six months, beating the S&P 500 by 5.6 percentage points.
Magic Formula Showdown: Why CVS Beats Qualcomm and Valero for Retirees
Joel Greenblatt's Magic Formula ranks stocks on earnings yield and return on capital, but for retirees those two numbers can point straight toward disaster. Three stocks cleared the screen, and only one survives when income reliability and volatility enter the equation.
CVS Just Turned Its 9,000 Pharmacies Into a GLP-1 Delivery Machine. 1 Top Wall Street Analyst Thinks That's a Reason to Buy the Stock
The stock is already up 30% this year.
TD Cowen Reaffirms Buy Rating on Salesforce (CRM) as AI Momentum and Agentforce Drive Growth
Salesforce Inc. (NYSE:CRM) ranks among the best set-it-and-forget-it stocks to buy right now. On June 12, TD Cowen reaffirmed its $240 price objective and Buy rating on Salesforce Inc. (NYSE:CRM). The update came after the firm hosted an investor dinner with new IR Senior Director Lauren O’Brien and the Vice President of Investor Relations, Valmik […]